Dysregulation of PI3K/Akt signalling in AD has also been shown to contribute to inflammation through modulation of cytokines, increase in oxidative stress through mitochondrial dysfunction, and dysregulation of cholinergic neurotransmission through modulation of acetylcholine (Ach) activity [90,91,92]. This evidence concerns the gene AKT1 and Alzheimer disease.